Fox Lake Towing and Recovery

As the crisis at Japan’s Fukushima Daiichi nuclear plant continues, some worry that radiation from the damaged reactors will reach U.S. shores. Dr. Edward Maher, president of the Health Physics Society, and an environmental science expert at Harvard, explains why we should breathe easy.

Continue reading Radiation Risk to U.S. from Japanese Reactors Very Low, Top Expert Explains

Radiation Risk to U.S. from Japanese Reactors Very Low, Top Expert Explains originally appeared on DailyFinance on Wed, 23 Mar 2011 17:00:00.

Filed Under: Health Care

Johnson & Johnson has issued another recall, and this time, it’s not over a typo. The company’s Animas unit recalled five lots of leaking insulin cartridges whose use could lead to serious health problems. The 2-milliliter cartridges can leak, resulting in the delivery of less insulin than intended.

Continue reading Johnson & Johnson Recalls Leaky Insulin Cartridges

Johnson & Johnson Recalls Leaky Insulin Cartridges originally appeared on DailyFinance on Tue, 08 Mar 2011 16:15:00.

Filed Under: Health Care, Johnson & Johnson

Japan’s health ministry says it’s continuing its suspension of pediatric vaccines made by Pfizer and Sanofi-Aventis, despite finding no connection between the vaccines and the deaths of four children. Both drugmakers are cooperating with the government and expect to be cleared.

Continue reading Japan Finds No Link Between Vaccines and Child Deaths

Japan Finds No Link Between Vaccines and Child Deaths originally appeared on DailyFinance on Tue, 08 Mar 2011 12:30:00.

Filed Under: Company News, Health Care, Pfizer, Sanofi Aventis

Stem cell research is still too hot for most investors, but NeoStem is starting to change that, thanks to some unexpected events. Among them are the Catholic Church’s surprising embrace of NeoStem’s research and NeoStem’s foothold in China’s vast health care market.

Continue reading Inside Wall Street: This Tiny Stem Cell Biotech Has the Vatican’s Backing

Inside Wall Street: This Tiny Stem Cell Biotech Has the Vatican’s Backing originally appeared on DailyFinance on Mon, 07 Mar 2011 07:30:00.

Filed Under: Company News, Technology, Columns, Investing, Health Care, Stock Picks

The odds of shepherding a new drug to market in recent years has fallen to nearly one in 10 — about half of the previous rate, according to a new study released this week. First, a new treatment must survive several layers of clinical studies — and then the FDA approval process. That trip is getting tougher.

Continue reading It’s Getting Harder to Come Up With a Successful Drug

It’s Getting Harder to Come Up With a Successful Drug originally appeared on DailyFinance on Thu, 17 Feb 2011 10:00:00.

Filed Under: Investing, Health Care